The NIHR funds will help to expand the research capacity of the pharmacy. Credit: Royal Free London NHS Foundation Trust.

Royal Free London in the UK has received approximately £4m ($5.05m) in funding from the National Institute for Health and Care Research (NIHR) to enhance its clinical research infrastructure.

The funds will be used to purchase advanced equipment, including a dedicated research MRI scanner, to expand the research capacity of the pharmacy and develop its clinical research laboratory.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

This investment will enable the hospital to support more new trials, including cell and gene therapy, and process and analyse samples from a growing portfolio of clinical studies at its laboratory.

Royal Free London research and development director Farhan Naim said: “This additional NIHR funding will provide a welcome boost to the clinical research infrastructure at RFL.

“The broad range of equipment that it will fund will go a long way in ensuring that we are able to realise our vision of offering optimal clinical research access to our local patient populations and staff.”

See Also:

Royal Free London anticipates that the new equipment and facilities will also strengthen collaborations with researchers in various fields, such as translational imaging and machine learning.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Royal Free London consultant cardiologist Dan Knight said: “The new low-field MRI scanner will support our groundbreaking research into interventional MRI, which we believe will significantly improve patient outcomes.

“This investment will also open up entirely new areas of imaging research in the unique patient populations served by the Royal Free Hospital such as those with pulmonary hypertension, connective tissue disease, and interstitial lung disease.”